It is suggested that EIF2AK4 variants are specific to PVOD/PCH and that finding biallelic EIF2AK4 variants in a patient with pulmonary hypertension would be diagnostic of PVOD/PCH. This evidence concerns the gene EIF2AK4 and pulmonary venoocclusive disease.